ARCHIVES

FDA Concerned About Data-Dredging In Drug-Diagnostic Applications

This article is from The Cancer Letter archive.

Vol. 35 No. 04 | January 30, 2009

Download PDF Visit The Full Archive

Related Articles

HER2+ Tumors Increase Risk Of Recurrence, Study Finds

November 27, 2009

Studies Are Demonstrating Effectiveness of Drug Combinations As Adjuvant Therapy; NCI Will Support New Clinical Trials

April 5, 1974

New Guidelines Developed For Cancer Control Granters For Community Outreach

June 4, 1976

Tempero, Johnson To Lead ASCO

March 28, 2003

COMMIT Moving Into Implementation

July 15, 1988

In Brief: Eight Site Visits at Prospective Comprehensive Centers Scheduled For NCCAB Members In ’75, 76

July 4, 1975